KPTIQ — Karyopharm Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.39m
- $257.57m
- $146.07m
U.S. STOCKS ON THE MOVE-IDEXX, Lumentum, Oracle
Karyopharm tumbles after bankruptcy filing, merger plan with Ayrmid
NASDAQ RESUMED AT 07:40 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:07 AM
Karyopharm Therapeutics Inc. expected to post a loss of 95 cents a share - Earnings Preview
Brief: Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
Karyopharm Therapeutics Inc. expected to post a loss of $1.28 a share - Earnings Preview
Karyopharm Therapeutics Inc. expected to post a loss of $1.28 a share - Earnings Preview
Karyopharm hits record low after endometrial cancer trial miss
U.S. RESEARCH ROUNDUP-Apple, Amazon, Mastercard
NASDAQ RESUMED AT 04:40 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Q1 net loss narrows
Brief: Karyopharm Therapeutics: Selling Stockholder May Resell Up To 8,843,036 Shares Of Karyopharm Common Stock - SEC Filing
Brief: Karyopharm Therapeutics May Offer Up To $400 Million In Securities - SEC Filing